Cardiotoxicity in childhood cancer survivors: a problem with long-term consequences in need of early detection and prevention.

about

Cardiovascular disease in adult survivors of childhood cancer.Arterial stiffness in childhood cancer survivors.Heart failure following blood cancer therapy in pediatric and adult populations.Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity.

P2860

Q34042984-B7CE27ED-4B1B-4E3B-AFDD-E99E28F62443 Q41038045-59756561-F135-4B42-A9EF-9093E10BAB16 Q47811419-02511DF6-86AA-4BE5-A144-0C1537AC3E81 Q49706717-2ACE747B-8070-462D-890A-2A60CA952F7D

P2860

Cardiotoxicity in childhood cancer survivors: a problem with long-term consequences in need of early detection and prevention.

Item

http://www.wikidata.org/entity/Q43983538

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Cardiotoxicity in childhood ca ...... arly detection and prevention.

@en

Cardiotoxicity in childhood ca ...... arly detection and prevention.

@nl

type

Item

label

Cardiotoxicity in childhood ca ...... arly detection and prevention.

@en

Cardiotoxicity in childhood ca ...... arly detection and prevention.

@nl

prefLabel

Cardiotoxicity in childhood ca ...... arly detection and prevention.

@en

Cardiotoxicity in childhood ca ...... arly detection and prevention.

@nl

P1476

Cardiotoxicity in childhood ca ...... arly detection and prevention.

@en

P2093

Thomas R Cochran

http://www.w3.org/2001/XMLSchema#string

Vivian I Franco

http://www.w3.org/2001/XMLSchema#string

P2860

Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes

Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes

The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.

Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective.

P304

1395-1396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.24597

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steven E Lipshultz

P577

2013-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23712966

http://www.w3.org/2001/XMLSchema#string

Cardiotoxicity in childhood cancer survivors: a problem with long-term consequences in need of early detection and prevention.

about

P2860

P2860

Cardiotoxicity in childhood cancer survivors: a problem with long-term consequences in need of early detection and prevention.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698